MDI (Molecular Diagnostics) and Ventana team up on imaging:
This article was originally published in Clinica
Tucson, Arizona-based Ventana Medical Systems has made an equity investment of $1.75 million in Molecular Diagnostics (MDI) and has purchased the rights to use Chicago-based MDI's AcCell automated microscopy workstation and Samba image analysis and telemedicine system software. "Our partnership with MDI significantly expands the breadth of imaging technologies available to Ventana," said Christopher Gleeson, Ventana's CEO. Access to the products will accelerate time to market, with launch date predicted in the second half of 2002.